7-92617798-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001145306.2(CDK6):​c.834+274G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.6 in 152,118 control chromosomes in the GnomAD database, including 28,519 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.60 ( 28519 hom., cov: 33)

Consequence

CDK6
NM_001145306.2 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.82

Publications

11 publications found
Variant links:
Genes affected
CDK6 (HGNC:1777): (cyclin dependent kinase 6) The protein encoded by this gene is a member of the CMGC family of serine/threonine protein kinases. This kinase is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression and G1/S transition. The activity of this kinase first appears in mid-G1 phase, which is controlled by the regulatory subunits including D-type cyclins and members of INK4 family of CDK inhibitors. This kinase, as well as CDK4, has been shown to phosphorylate, and thus regulate the activity of, tumor suppressor protein Rb. Altered expression of this gene has been observed in multiple human cancers. A mutation in this gene resulting in reduced cell proliferation, and impaired cell motility and polarity, and has been identified in patients with primary microcephaly. [provided by RefSeq, Aug 2017]
CDK6 Gene-Disease associations (from GenCC):
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • microcephaly 12, primary, autosomal recessive
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 7-92617798-C-T is Benign according to our data. Variant chr7-92617798-C-T is described in ClinVar as [Benign]. Clinvar id is 1232569.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.786 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDK6NM_001145306.2 linkc.834+274G>A intron_variant Intron 7 of 7 ENST00000424848.3 NP_001138778.1 Q00534
CDK6NM_001259.8 linkc.834+274G>A intron_variant Intron 7 of 7 NP_001250.1 Q00534
CDK6XM_047419716.1 linkc.834+274G>A intron_variant Intron 7 of 7 XP_047275672.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDK6ENST00000424848.3 linkc.834+274G>A intron_variant Intron 7 of 7 1 NM_001145306.2 ENSP00000397087.3 Q00534
CDK6ENST00000265734.8 linkc.834+274G>A intron_variant Intron 7 of 7 1 ENSP00000265734.4 Q00534
CDK6ENST00000467166.1 linkn.206+274G>A intron_variant Intron 1 of 1 2

Frequencies

GnomAD3 genomes
AF:
0.600
AC:
91145
AN:
152002
Hom.:
28467
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.755
Gnomad AMI
AF:
0.444
Gnomad AMR
AF:
0.689
Gnomad ASJ
AF:
0.513
Gnomad EAS
AF:
0.807
Gnomad SAS
AF:
0.403
Gnomad FIN
AF:
0.498
Gnomad MID
AF:
0.500
Gnomad NFE
AF:
0.506
Gnomad OTH
AF:
0.589
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.600
AC:
91261
AN:
152118
Hom.:
28519
Cov.:
33
AF XY:
0.602
AC XY:
44733
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.756
AC:
31368
AN:
41512
American (AMR)
AF:
0.690
AC:
10546
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.513
AC:
1778
AN:
3468
East Asian (EAS)
AF:
0.807
AC:
4172
AN:
5172
South Asian (SAS)
AF:
0.404
AC:
1946
AN:
4822
European-Finnish (FIN)
AF:
0.498
AC:
5270
AN:
10580
Middle Eastern (MID)
AF:
0.507
AC:
149
AN:
294
European-Non Finnish (NFE)
AF:
0.506
AC:
34394
AN:
67968
Other (OTH)
AF:
0.587
AC:
1235
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1828
3656
5483
7311
9139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
732
1464
2196
2928
3660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.572
Hom.:
11826
Bravo
AF:
0.625
Asia WGS
AF:
0.632
AC:
2196
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 18, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.24
DANN
Benign
0.48
PhyloP100
-1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs42042; hg19: chr7-92247112; API